Allogeneic Progenitor Cell Transplantation (Pct) For High-Risk Patients With Advanced Hematologic Malignancies Using Fludarabine (Flu) Plus Non-Myeloablative Doses (Nmd) Of Intravenous (Iv) Busulfan (Bu). Results Of A Phase I/Ii Trial.
BLOOD（2002）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要